✦ LIBER ✦

A feasibility study of the efficacy and tolerability of the combination of Exemestane with the COX-2 inhibitor Celecoxib in post-menopausal patients with advanced breast cancer

✍ Scribed by P.A. Canney; M.A. Machin; J. Curto

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II nonrandomized study of the effi

✍ Giovanni Mantovani; Antonio Macciò; Clelia Madeddu; Roberto Serpe; Giorgia Anton 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 179 KB

Tolerance and efficacy of the antiestrog

✍ H. Stamm; R. Roth; A. Almendral; H.J. Staab; M. Heil 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 106 KB

Everolimus in Combination with Exemestan

✍ Sohita Dhillon 📂 Article 📅 2013 🏛 Springer International Publishing AG 🌐 English ⚖ 426 KB

Pre-surgical study of the biological eff

✍ Lesley-Ann Martin; Giles L. S. Davies; Marion T. Weigel; Nadine Betambeau; Marga 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 327 KB

Inhibition of growth of human breast can

✍ L. Witters; M. Javeed; J. Crispino; J. Green; J. Seaman; D. Reitsma; T. Kamal; L 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 170 KB

The oral mTOR inhibitor RAD001 (everolim

✍ Ahmad Awada; Fatima Cardoso; Christel Fontaine; Luc Dirix; Jacques De Grève; Chr 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 175 KB